JP2025513284A5 - - Google Patents
Info
- Publication number
- JP2025513284A5 JP2025513284A5 JP2024561595A JP2024561595A JP2025513284A5 JP 2025513284 A5 JP2025513284 A5 JP 2025513284A5 JP 2024561595 A JP2024561595 A JP 2024561595A JP 2024561595 A JP2024561595 A JP 2024561595A JP 2025513284 A5 JP2025513284 A5 JP 2025513284A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antigen
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263333064P | 2022-04-20 | 2022-04-20 | |
| US63/333,064 | 2022-04-20 | ||
| PCT/US2023/066018 WO2023205739A2 (en) | 2022-04-20 | 2023-04-20 | Antigen-binding domains and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513284A JP2025513284A (ja) | 2025-04-24 |
| JP2025513284A5 true JP2025513284A5 (https=) | 2026-04-28 |
Family
ID=88420756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561595A Pending JP2025513284A (ja) | 2022-04-20 | 2023-04-20 | 抗原結合ドメインおよびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250032548A1 (https=) |
| EP (1) | EP4511403A4 (https=) |
| JP (1) | JP2025513284A (https=) |
| KR (1) | KR20250006910A (https=) |
| CN (1) | CN119013306A (https=) |
| AU (1) | AU2023256674A1 (https=) |
| CA (1) | CA3247456A1 (https=) |
| TW (1) | TW202346340A (https=) |
| WO (1) | WO2023205739A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050266008A1 (en) * | 2004-03-29 | 2005-12-01 | Medarex, Inc. | Human anti-IRTA-5 antibodies |
| WO2013063114A1 (en) * | 2011-10-24 | 2013-05-02 | Abbvie Inc. | Immunobinders directed against tnf |
| WO2017173327A1 (en) * | 2016-03-31 | 2017-10-05 | The Schepens Eye Research Institute, Inc. | Endomucin inhibitor as an anti-angiogenic agent |
| CU24731B1 (es) * | 2017-10-06 | 2025-01-15 | Prothena Biosciences Ltd | Anticuerpos anti-transtiretina |
| CN115298209A (zh) * | 2020-02-20 | 2022-11-04 | 森迪生物科学公司 | 抑制性嵌合受体构造体 |
| KR20230109138A (ko) * | 2020-10-16 | 2023-07-19 | 센티 바이오사이언시스, 인코포레이티드 | 키메라 수용체 및 이의 사용 방법 |
| AU2023256633A1 (en) * | 2022-04-21 | 2024-12-05 | Senti Biosciences, Inc. | Multicistronic chimeric protein expression systems |
-
2023
- 2023-04-20 KR KR1020247038321A patent/KR20250006910A/ko active Pending
- 2023-04-20 AU AU2023256674A patent/AU2023256674A1/en active Pending
- 2023-04-20 CA CA3247456A patent/CA3247456A1/en active Pending
- 2023-04-20 EP EP23792787.6A patent/EP4511403A4/en active Pending
- 2023-04-20 CN CN202380034192.5A patent/CN119013306A/zh active Pending
- 2023-04-20 JP JP2024561595A patent/JP2025513284A/ja active Pending
- 2023-04-20 WO PCT/US2023/066018 patent/WO2023205739A2/en not_active Ceased
- 2023-04-20 TW TW112114785A patent/TW202346340A/zh unknown
-
2024
- 2024-10-18 US US18/920,680 patent/US20250032548A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7333104B2 (ja) | Ｂ７－ｈ３に対するモノクローナル抗体および細胞治療におけるその使用 | |
| RU2748281C2 (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| JP7401538B2 (ja) | 抗ｃｌｄｎ１８．２抗体およびその使用 | |
| CN111018986B (zh) | 抗磷脂酰肌醇蛋白多糖-3的抗体及其应用 | |
| US20260062493A1 (en) | Antibody Targeting BCMA, Bispecific Antibody, And Use Thereof | |
| JP2021524267A5 (https=) | ||
| JP2020532965A5 (https=) | ||
| US12492252B2 (en) | Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibody | |
| CN117285642A (zh) | 制导和导航控制蛋白及其制备和使用方法 | |
| JP2018533371A5 (https=) | ||
| JPWO2019129221A5 (https=) | ||
| HRP20110187T1 (hr) | Multispecifične deimunizirane tvari koje vežu cd3 | |
| CN113853388B (zh) | 抗-egfrviii抗体及其抗原结合片段 | |
| US20180346591A1 (en) | Bispecific antibody for cancer immunotherapy | |
| RU2013106217A (ru) | Гибридный белок из антитела против мнс и противовирусного цитокина | |
| CN115038718A (zh) | 抗人程序性死亡配体-1（pd-l1）的抗体及其用途 | |
| WO2025246679A1 (zh) | 一种广谱中和冠状病毒的抗体及其应用 | |
| CN113164538A (zh) | 修饰的溶瘤病毒、其组合物和用途 | |
| KR20220164787A (ko) | 암 및 감염의 치료를 위한 NKp46에 대한 항체 및 이의 작제물 | |
| CN114920841B (zh) | 抗cd87抗体及其特异性嵌合抗原受体 | |
| US20240270840A1 (en) | Antibodies against cd112r and uses thereof | |
| IL302148A (en) | Chimeric receptors and methods of use thereof | |
| CN116265486A (zh) | 结合人cd73的抗体、其制备方法和用途 | |
| JP2025513284A5 (https=) | ||
| JPWO2021116337A5 (https=) |